RxDoctor Payments Data

Janna Tuck

Allergy & Immunology · Santa Fe, NMNPI 1346230646

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 26.5% of the total.

$3,609in general payments, 2019–2025

Across 185 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$956
  • GSK$710
  • CSL Behring$424
  • Takeda Pharmaceuticals U.S.A., Inc.$303
  • Grifols USA, LLC$146
  • Shire North American Group Inc$141
  • plus $928 from 15 others

What the payments were for

  • Food & beverage$3,598100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few allergy & immunology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Other allergy & immunology in Santa Fe

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →